Key result
Preclinical testing of the Heartmate III left ventricular assist system in calves demonstrated good in vivo performance at an average flow rate of 6 L/min, alongside 16-40 months of in vitro reliability.
The HeartMate III LVAD with a magnetically levitated rotor demonstrates promising preclinical in vivo performance and long-term in vitro reliability.
Answers are grounded in this paper and cite their sources.
Supports progression to human trials of HeartMate III; leaves open clinical safety and efficacy.
A long-term left ventricular assist system for permanent use in advanced heart failure is being developed on the basis of a compact centrifugal pump with a magnetically levitated rotor and single-fault-tolerant electronics. Key features include its "bearingless" (magnetic levitation) design, textured surfaces similar to the HeartMate XVE left ventricular assist device (LVAD) to reduce anticoagulation requirements and thromboembolism, a sensorless flow estimator, and an induced pulse mode for achieving an increased level of pulsatility with continuous flow assistance. In vitro design verification testing is underway. Preclinical testing has been performed in calves demonstrating good in vivo performance at an average flow rate of 6 L/min (maximum: >11 L/min) and normal end-organ function and host response. Induced pulse mode demonstrated the ability to produce a physiological pulse pressure in vivo. Thirteen LVADs have achieved between 16 to 40 months of long-term in vitro reliability testing and will be continued until failure. Both percutaneous and fully implanted systems are in development, with a modular connection for upgrading without replacing the LVAD.
No takes yet. Share an insight, caveat, or question.
Farrar et al. (2007) studied Advanced heart failure. Heartmate III Centrifugal Left Ventricular Assist System was evaluated. Preclinical testing of the Heartmate III left ventricular assist system in calves demonstrated good in vivo performance at an average flow rate of 6 L/min, alongside 16-40 months of in vitro reliability.
Synapse has enriched 10 related papers. Consider them for comparative context: